EXENCIAL WEALTH ADVISORS, LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
EXENCIAL WEALTH ADVISORS, LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$320,568
+0.3%
8,494
+21.1%
0.02%
+6.7%
Q2 2023$319,555
+21.4%
7,014
+8.0%
0.02%
+7.1%
Q1 2023$263,297
-95.2%
6,492
-92.4%
0.01%
-95.5%
Q2 2022$5,521,000
-20.8%
85,952
-4.4%
0.31%
-10.9%
Q1 2022$6,969,000
-11.0%
89,874
-1.5%
0.35%
-7.7%
Q4 2021$7,833,000
-16.2%
91,253
-21.5%
0.38%
-6.7%
Q3 2021$9,345,000
+46.3%
116,184
+46.4%
0.41%
+17.7%
Q2 2021$6,387,000
+0.6%
79,339
+5.4%
0.34%
-8.2%
Q1 2021$6,347,000
+22.0%
75,257
+16.0%
0.38%
+5.9%
Q4 2020$5,204,000
-3.9%
64,856
-3.7%
0.36%
+23.7%
Q3 2020$5,414,000
+0.5%
67,322
+7.6%
0.29%
-38.5%
Q2 2020$5,388,000
+24.9%
62,579
+17.8%
0.47%
-39.3%
Q1 2020$4,313,000
+7.5%
53,119
+10.7%
0.77%
+10.6%
Q4 2019$4,012,000
+2.3%
47,975
+7.0%
0.70%
-17.6%
Q3 2019$3,922,000
+12.7%
44,835
+5.5%
0.84%
+3.8%
Q2 2019$3,480,000
-3.8%
42,485
-4.5%
0.81%
-5.5%
Q1 2019$3,617,000
+27.1%
44,483
+2.9%
0.86%
+12.4%
Q4 2018$2,845,000
-11.9%
43,228
+3.2%
0.76%
+1.7%
Q3 2018$3,229,000
+16.1%
41,884
+11.2%
0.75%
-3.1%
Q2 2018$2,782,000
+25.2%
37,675
+10.3%
0.78%
+17.2%
Q1 2018$2,222,000
+11.4%
34,159
+10.7%
0.66%
+10.0%
Q4 2017$1,994,000
+36.7%
30,850
+32.6%
0.60%
+24.9%
Q3 2017$1,459,000
+2291.8%
23,258
+2561.1%
0.48%
+1750.0%
Q1 2013$61,0008740.03%
Other shareholders
BAXTER INTL INC shareholders Q2 2022
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders